The 36-month beta value for EVO is at 1.70. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for EVO is 336.66M, and currently, shorts hold a 0.24% of that float. The average trading volume for EVO on April 17, 2025 was 72.77K shares.
EVO) stock’s latest price update
Evotec SE ADR (NASDAQ: EVO) has seen a rise in its stock price by 10.76 in relation to its previous close of 3.27. However, the company has experienced a 18.36% gain in its stock price over the last five trading sessions. accessnewswire.com reported 2025-04-17 that Evotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growth Strategy builds on technology and science leadership, focusing on high-growth, high-value segments, simplifying the business model and fostering operational excellence Strong Q4 2024 revenue and EBITDA results in spite of challenging market conditions. Full year guidance met, with liquidity significantly improved Priority Reset on track to deliver annualised recurring gross savings of € 40 m 2025 guidance: group revenues to grow 5 – 10 % (€ 840 – 880 m); 2028 outlook foresees revenue CAGR2024-2028 between 8 – 12% and generation of EBITDA margin above 20 % HAMBURG, GERMANY / ACCESS Newswire / April 17, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN:DE0005664809; NASDAQ:EVO) today announced its financial results for FY 2024, provided guidance for FY 2025 and outlook for 2028 reflecting the path to sustainable profitable growth, following the completion of its strategic review process.
EVO’s Market Performance
Evotec SE ADR (EVO) has experienced a 18.36% rise in stock performance for the past week, with a 0.32% rise in the past month, and a -10.35% drop in the past quarter. The volatility ratio for the week is 3.74%, and the volatility levels for the past 30 days are at 3.96% for EVO. The simple moving average for the past 20 days is 9.85% for EVO’s stock, with a -10.00% simple moving average for the past 200 days.
Analysts’ Opinion of EVO
Morgan Stanley gave a rating of “Equal-Weight” to EVO, setting the target price at $6 in the report published on July 29th of the previous year.
EVO Trading at -3.87% from the 50-Day Moving Average
After a stumble in the market that brought EVO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.39% of loss for the given period.
Volatility was left at 3.96%, however, over the last 30 days, the volatility rate increased by 3.74%, as shares surge +4.26% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.08% lower at present.
During the last 5 trading sessions, EVO rose by +19.93%, which changed the moving average for the period of 200-days by -24.49% in comparison to the 20-day moving average, which settled at $3.30. In addition, Evotec SE ADR saw -12.94% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for EVO
Current profitability levels for the company are sitting at:
- -0.24 for the present operating margin
- 0.14 for the gross margin
The net margin for Evotec SE ADR stands at -0.22. The total capital return value is set at -0.11. Equity return is now at value -16.21, with -8.05 for asset returns.
Currently, EBITDA for the company is 24.12 million with net debt to EBITDA at 1.32. When we switch over and look at the enterprise to sales, we see a ratio of 1.18. The receivables turnover for the company is 3.41for trailing twelve months and the total asset turnover is 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.09.
Conclusion
In conclusion, Evotec SE ADR (EVO) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
